Archon Corporation (ARHN) 18.0000 $ARHN Esplanade

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Archon Corporation (ARHN) 18.0000 $ARHN

Esplanade Capital Raises Offer For Archon Corporation to $19.25 per Share
Business Wire - Thu Jan 16, 9:00AM CST
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has raised its offer to acquire all outstanding shares of Archon Corporation to a price of $19.25 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered a letter to Archon's board of directors, the full text of which follows:

Esplanade Capital Raises Offer For Archon Corporation to $18.50 Per Share
Business Wire - Tue Jun 04, 9:00AM CDT
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has raised its offer to acquire all outstanding shares of Archon Corporation to a price of $18.50 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered a letter to Archon's board of directors, the full text of which follows:

Lifshitz Law Firm Announces Investigation of Anaren, Inc., Archon Corporation, Life Technologies Corporation and National Financial Partners Corp.
PR Newswire - Mon Apr 22, 2:03PM CDT
Anaren, Inc.

Rigrodsky & Long, P.A. Announces Investigation Of Archon Corporation Proposed Buyout
Business Wire - Sat Apr 20, 12:05PM CDT
Rigrodsky & Long, P.A.:

Archon Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Archon Corp. Concerning the Receipt of an Acquisition Proposal from Esplanade Capital
Business Wire - Thu Apr 18, 2:44PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating potential claims against the Board of Directors of Archon Corporation ("Archon") (OTC: ARHN) concerning the board's receipt of an acquisition proposal from Esplanade Capital, the second largest outside shareholder of Archon. Under the proposal, Esplanade Capital made an offer to acquire all of outstanding shares of Archon common stock for $17.50 per share.

Investor Alert: Former Attorney General of Louisiana and Kahn Swick & Foti, LLC Investigate Archon Corporation Following Announcement of Proposed Sale of Company to Esplanade Capital, LLC
Business Wire - Wed Apr 17, 12:09PM CDT
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC announce that KSF has commenced an investigation into the Board of Directors of Archon Corporation ("Archon" or the "Company) (OTC US: ARHN) in connection with their conduct related to the sale of the Company to Esplanade Capital, LLC, Archon's second largest outside shareholder. Under the terms of the proposed transaction, shareholders of Archon will receive $17.50 in cash for each share of Archon common stock that they own.

Faruqi & Faruqi, LLP is Investigating Archon Corporation (ARHN) for Potential Breaches of Fiduciary Duties
Business Wire - Tue Apr 16, 6:01PM CDT
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Archon Corporation ("Archon" or the "Company") (OTC US: ARHN) for potential breaches of fiduciary duties in connection with their conduct related to the proposed sale of the Company to Esplanade Capital LLC, the Company's second largest outside shareholder, in an all-cash deal valued at approximately $101 million. The proposed transaction offers Archon's shareholders $17.50 in cash for each share of Archon common stock they own.

Esplanade Capital Urges Board of Archon Corporation to Consider Its Offer to Acquire the Company
Business Wire - Mon Apr 15, 9:00AM CDT
Esplanade Capital LLC, the second largest outside shareholder (based on Bloomberg data) of Archon Corporation (OTC: ARHN), has made an offer to acquire all outstanding shares of Archon Corporation at a price of $17.50 per share in a negotiated transaction, subject to confirmatory due diligence. Esplanade Capital has delivered two letters to Archon's board of directors, the full texts of which follow:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 144

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 78

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 110

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 150

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading

Top 5 Most Recently Viewed Articles

Vinanz Boosts Bitcoin Mining Operations with New Hardware

Updated Category News Views 160

Vinanz Limited Enhances Bitcoin Mining Capacity Vinanz Limited (US OTCQB: VINZF and AQSE: BTC) has taken a significant step forward in its operations by activating new Bitcoin mining hardware in Nebraska. This move aligns with its broader strategy to expand Bitcoin mining capabilities across North America. Introduction of Advanced Mining Technology The recent deployment...

Continue Reading
Recent Transparency Notification by Nyxoah - Key Insights

Updated Category News Views 202

Understanding Nyxoah's Recent Transparency Notification REGULATED INFORMATION Mont-Saint-Guibert – In alignment with disclosure requirements regarding shareholding changes, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an important transparency notification. Who is Vestal Point Capital? On October 23, Nyxoah disclosed that it received a transparency...

Continue Reading
Mural Oncology Set to Showcase Research at SITC Annual Meeting

Updated Category News Views 48

Mural Oncology Set to Showcase Research at SITC Annual Meeting Mural Oncology plc (NASDAQ: MURA), a pioneering company focused on immuno-oncology, is gearing up for a significant event—the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). This important gathering will take place from November 6-10, 2024, in Houston, Texas. Mural Oncology is excited...

Continue Reading
Genmab A/S Announces Share Buyback Progress and Strategy

Updated Category News Views 128

Overview of Genmab's Share Buyback Program Genmab A/S has initiated an impressive share buyback program aimed at enhancing shareholder value. The program, announced on March 25, is designed to repurchase up to 2.2 million shares as part of its strategy to reduce capital and fulfill commitments under the Restricted Stock Unit program. Recent Transactions Under the Buyback...

Continue Reading